Quick Dispatch:
Your soul trial oral semaglutide cardiovascular outcomes results NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your soul trial oral semaglutide cardiovascular outcomes results NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM ships.
Need Help?
Questions about soul trial oral semaglutide cardiovascular outcomes results NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for soul trial oral semaglutide cardiovascular outcomes results NEJM Editorial Fellow Harleen Marwah, MD, summarizes the SOUL trial. Read the full trial results at NEJM.org (link in bio). , , #ACC25 #Cardiology #ClinicalTrials #NEJM in your area.
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
22.67
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
22.42
Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice
22.82
ADA 2025: Oral Semaglutide Demonstrates Cardiovascular Benefits in SOUL Trial
21.59
Rethinking the Standard of Care:
21.58
Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes | Cardiovascular Diabetology
20.05
Comparative cardiovascular outcomes of semaglutide to dulaglutide in patients with type 2 diabetes
22.85
